Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have received an average recommendation of “Hold” from the eighteen analysts that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and nine have issued a buy rating on the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $45.83.

ACHC has been the subject of several recent research reports. Mizuho set a $60.00 price target on Acadia Healthcare and gave the company a “buy” rating in a research note on Tuesday, October 24th. Jefferies Group set a $60.00 price target on Acadia Healthcare and gave the company a “buy” rating in a research note on Wednesday, October 11th. KeyCorp restated a “buy” rating and set a $59.00 price objective on shares of Acadia Healthcare in a research report on Friday, October 20th. Craig Hallum restated a “buy” rating and set a $41.00 price objective (down from $65.00) on shares of Acadia Healthcare in a research report on Thursday, October 26th. Finally, Citigroup lowered their price objective on shares of Acadia Healthcare from $61.00 to $44.00 and set a “buy” rating for the company in a research report on Wednesday, October 25th.

Shares of Acadia Healthcare (ACHC) opened at $32.25 on Tuesday. The company has a debt-to-equity ratio of 1.30, a current ratio of 1.36 and a quick ratio of 1.36. The stock has a market capitalization of $2,833.28, a P/E ratio of 16.37, a P/E/G ratio of 1.20 and a beta of 0.90. Acadia Healthcare has a 12 month low of $26.92 and a 12 month high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.07). The company had revenue of $716.70 million during the quarter, compared to the consensus estimate of $728.86 million. Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The company’s quarterly revenue was down 2.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.58 earnings per share. research analysts predict that Acadia Healthcare will post 2.23 EPS for the current year.

In other Acadia Healthcare news, Director Reeve B. Waud sold 100,000 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $31.80, for a total transaction of $3,180,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 11.10% of the stock is owned by insiders.

Several large investors have recently made changes to their positions in the company. Pacer Advisors Inc. increased its holdings in shares of Acadia Healthcare by 2.2% during the second quarter. Pacer Advisors Inc. now owns 10,365 shares of the company’s stock worth $512,000 after buying an additional 226 shares in the last quarter. People s United Financial Inc. increased its holdings in shares of Acadia Healthcare by 3.4% during the second quarter. People s United Financial Inc. now owns 7,459 shares of the company’s stock worth $368,000 after buying an additional 242 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Acadia Healthcare by 11.1% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after buying an additional 270 shares in the last quarter. M&T Bank Corp increased its holdings in shares of Acadia Healthcare by 12.6% during the second quarter. M&T Bank Corp now owns 5,934 shares of the company’s stock worth $293,000 after buying an additional 664 shares in the last quarter. Finally, Utah Retirement Systems increased its holdings in shares of Acadia Healthcare by 7.5% during the second quarter. Utah Retirement Systems now owns 14,300 shares of the company’s stock worth $706,000 after buying an additional 1,000 shares in the last quarter.

COPYRIGHT VIOLATION NOTICE: “Acadia Healthcare Company, Inc. (ACHC) Receives Consensus Recommendation of “Hold” from Analysts” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/acadia-healthcare-company-inc-achc-receives-consensus-recommendation-of-hold-from-analysts/1783335.html.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with Analyst Ratings Network's FREE daily email newsletter.